Natera shared on LinkedIn:
“Community oncologist Dr. José Alemar shares how Signatera MRD testing can help detect cancer recurrence earlier than standard of care tools.
Learn more: Transforming the management of cancer with personalized testing.”
Other articles about Signatera on OncoDaily.